Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.
Approximately 13% of boys with Duchenne muscular dystrophy (DMD) have a nonsense mutation in the dystrophin gene, resulting in a premature stop codon in the corresponding mRNA and failure to generate a functional protein. Ataluren (PTC124) enables ribosomal readthrough of premature stop codons, lead...
Main Authors: | Richard S Finkel, Kevin M Flanigan, Brenda Wong, Carsten Bönnemann, Jacinda Sampson, H Lee Sweeney, Allen Reha, Valerie J Northcutt, Gary Elfring, Jay Barth, Stuart W Peltz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3859499?pdf=render |
Similar Items
-
Analysis of dystrophin in duchenne muscular dystrophy and SMN in spinal muscular atrophy /
by: Coovert, Daniel David
Published: (1998) -
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
by: Yingyin Liang, et al.
Published: (2015-05-01) -
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
by: van Ommen Gert Jan B, et al.
Published: (2011-04-01) -
One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
by: Lucia Ruggiero, et al.
Published: (2018-11-01) -
Brain Dystrophin in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-10-01)